MX385994B - Formulaciones para el tratamiento de lesiones de la mucosa. - Google Patents

Formulaciones para el tratamiento de lesiones de la mucosa.

Info

Publication number
MX385994B
MX385994B MX2017016029A MX2017016029A MX385994B MX 385994 B MX385994 B MX 385994B MX 2017016029 A MX2017016029 A MX 2017016029A MX 2017016029 A MX2017016029 A MX 2017016029A MX 385994 B MX385994 B MX 385994B
Authority
MX
Mexico
Prior art keywords
formulations
treatment
lesions
mucosal lesions
mucous
Prior art date
Application number
MX2017016029A
Other languages
English (en)
Other versions
MX2017016029A (es
Inventor
Raman Mehta
Original Assignee
Raman Mehta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raman Mehta filed Critical Raman Mehta
Publication of MX2017016029A publication Critical patent/MX2017016029A/es
Publication of MX385994B publication Critical patent/MX385994B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a formulaciones que contienen una combinación de extractos de Curcuma longa, Punica granatum y Zingiber officinale, utilizadas para el tratamiento y prevención de lesiones de la mucosa, en particular los causados por el virus del Herpes o el síndrome de Behcet. Las formulaciones son especialmente efectivas en reducir la incidencia de lesiones de la mucosa en la boca, garganta y área genital.
MX2017016029A 2015-06-10 2016-06-10 Formulaciones para el tratamiento de lesiones de la mucosa. MX385994B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15171355.9A EP3103465A1 (en) 2015-06-10 2015-06-10 Formulations for the treatment of mucosal lesions
PCT/IB2016/000791 WO2016198942A1 (en) 2015-06-10 2016-06-10 Formulations for the treatment of mucosal lesions

Publications (2)

Publication Number Publication Date
MX2017016029A MX2017016029A (es) 2018-04-13
MX385994B true MX385994B (es) 2025-03-18

Family

ID=53385534

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016029A MX385994B (es) 2015-06-10 2016-06-10 Formulaciones para el tratamiento de lesiones de la mucosa.

Country Status (14)

Country Link
US (1) US10786540B2 (es)
EP (2) EP3103465A1 (es)
JP (1) JP6830482B2 (es)
KR (1) KR20180030482A (es)
CN (1) CN108012530B (es)
AU (1) AU2016276144B2 (es)
BR (1) BR112017026422B1 (es)
ES (1) ES2728557T3 (es)
HU (1) HUE045225T2 (es)
MX (1) MX385994B (es)
PL (1) PL3307292T3 (es)
PT (1) PT3307292T (es)
TR (1) TR201908166T4 (es)
WO (1) WO2016198942A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023037299A1 (en) * 2021-09-09 2023-03-16 Integria Healthcare (Australia) Pty Limited Anti-inflammatory compositions comprising ginger and turmeric

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US6596313B2 (en) 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US7175987B2 (en) * 2002-08-06 2007-02-13 The Quigley Corporation Compositions and methods for treatment of herpes
MXPA05001051A (es) * 2002-08-06 2005-04-08 The Quigley Corp Composiciones anti-microbianas y metodos para usar las mismas.
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
US20090175971A1 (en) 2008-01-08 2009-07-09 Mark Dreher Method of using composition comprising pomegranate extracts against the common cold
DE202009002126U1 (de) * 2009-02-13 2009-04-16 Orthomol Pharmazeutische Vertriebs Gmbh Spurenelement enthaltende Zusammensetzung
KR101077920B1 (ko) 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
RU2012127803A (ru) * 2009-12-04 2014-01-20 Колгейт-Палмолив Компани Оральная композиция, содержащая сочетание природных экстрактов, и соответствующие способы
IT1402018B1 (it) 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
JP2013001666A (ja) * 2011-06-14 2013-01-07 Yasuharu Omura 栄養剤組成物
CN102670588B (zh) 2012-05-04 2013-11-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 鞣花酸用于制备抗病毒药物的应用
CN103638502B (zh) * 2013-12-12 2015-07-01 苏振华 一种治疗白塞病的药物及其制备方法
CN103690709B (zh) * 2013-12-14 2016-03-09 青岛市中心医院 一种治疗肠白塞病的中药
CN104524508A (zh) 2014-12-24 2015-04-22 赵红 一种治疗消化性溃疡的中药及其制备方法
EP3103464A1 (en) * 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of disorders of the mouth, throat and respiratory tract

Also Published As

Publication number Publication date
JP2018521124A (ja) 2018-08-02
BR112017026422B1 (pt) 2021-10-05
AU2016276144B2 (en) 2022-01-13
EP3103465A1 (en) 2016-12-14
BR112017026422A2 (pt) 2018-08-21
CN108012530A (zh) 2018-05-08
TR201908166T4 (tr) 2019-06-21
PT3307292T (pt) 2019-05-31
MX2017016029A (es) 2018-04-13
US10786540B2 (en) 2020-09-29
ES2728557T3 (es) 2019-10-25
PL3307292T3 (pl) 2020-01-31
EP3307292A1 (en) 2018-04-18
AU2016276144A1 (en) 2017-12-21
HUE045225T2 (hu) 2019-12-30
US20180104301A1 (en) 2018-04-19
KR20180030482A (ko) 2018-03-23
WO2016198942A1 (en) 2016-12-15
JP6830482B2 (ja) 2021-02-17
EP3307292B1 (en) 2019-03-13
CN108012530B (zh) 2021-07-02

Similar Documents

Publication Publication Date Title
MX385397B (es) Bacteria manejada genéticamente para producir butirato, interleucina-10 y/o interleucina-22 para tratar enfermedades que se benefician de inflamación intestinal reducida y/o barrera mucosa intestinal fortalecida.
MX378584B (es) Formulaciones para el tratamiento de trastornos de la boca, garganta y tracto respiratorio.
WO2015120110A3 (en) Novel pharmaceutical formulations
MX369474B (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.
WO2017136792A8 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
HK1223301A1 (zh) 基於鼻内递送中和抗体以增强治疗效力的组合物和方法
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CY1119633T1 (el) Νεες φαρμακοτεχνικες μορφες αποτελουμενες απο φυτικα εκχυλισματα
WO2016056026A3 (en) Synergistic composition for osteoarthritis
CL2019002325A1 (es) Combinaciones farmacéuticas para tratar cáncer.
RU2016133688A (ru) Композиции, содержащие экстракты Curcuma Longa и Echinacea angustifolia, которые являются полезными для уменьшения периферического воспаления и боли
MX385994B (es) Formulaciones para el tratamiento de lesiones de la mucosa.
EA202090164A1 (ru) Изотретиноиновые перорально-слизистые композиции и способы их применения
AR099299A1 (es) Inhibidor de la proteína de transferencia de éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden dicho inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
EA201590678A1 (ru) Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w
MY189021A (en) Peptides and uses therefor as antiviral agents
MX2021006654A (es) Uso de extracto de cocculus hirsutus para tratar dengue.
MA40805A (fr) Compositions pharmaceutiques à action prolongée contre l'hépatite c
EA201790974A1 (ru) Освежитель для полости рта
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
PH12017501943B1 (en) Influenza virus neutralizing peptidomimetic compounds
MX2023001145A (es) Supresion de liberacion de citocina y tormenta de citocinas.
MX2021005257A (es) Composicion inmunogenica contra el subtipo h5 del virus de la influenza aviar.
WO2018056528A3 (ko) 인플루엔자 b 백신
NZ734491A (en) Method to solubilize curcuminoids in water